Original article

Degradation of PTEN mRNA by microRNA-29 family promotes survival and lymph node invasion of non-small cell lung cancer cell

Expand
  • Department of Oncology, Shanghai 9th People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201900, China

Received date: 2020-09-16

  Online published: 2022-07-26

Abstract

Objective To investigate the regulation and the underlying molecular mechanism of microRNA(miRNA/miR)-29 family on the cancer cell proliferation and invasion of human lymph-node invasive non-small cell lung cancer (NSCLC). Methods TCGA data base was used to analyze phosphatase and tension homology deleted from chromosome 10 (PTEN) and the mRNA expression between the non-lymph node invasive and lymph node invasive tissue in NSCLC patients. The PTEN protein expression in non-lymph node invasive NSCLC A549 cells and lymph node invasive NSCLC H1299 cells was detected by Western blotting. Three different online software were used to predict the miRNAs targeting PTEN mRNA. Real-time quantitative reverse transcriptase mediated (qRT-PCR) was used to detect miR-29 family expression in A549 cells and H1299 cells. The binding sites between PTEN mRNA 3’ untranslated region(UTR) and miR-29 were predicted by using database and confirmed by luciferase report assays. miR-a/b/c mimics or inhibitors were transfected to A549 or H1299 cells, and the PTEN protein expression was detected by Western blotting. miR-29 family knock-down cells were established by CRISPR cas9 technology. Cell counting kit-8(CCK-8) assay was used to detect the difference of proliferation between negative control group (NC group) and miR-29 family knock-down group, and transwell invasion chamber test was used to detect the difference in invasion. p-Akt,Akt, phosphorylation focal adhesion kinase(p-FAK), FAK and survivn expression was detected by Western blotting. Survivin mRNA expression was measured by qRT-PCR. CCK-8 method was used to detect the cell proliferation and cell invasion was detected by transwell method. Results The PTEN mRNA expression in the non-lymph node invasive NSCLC patients was higher than that in lymph node invasive NSCLC patients by analyzing the TCGA database. The PTEN protein expression was higher in A549 cells than that in H1299 cells, while miR-29 family expression was lower in A549 cells than that in H1299 cells. The luciferase report assays confirmed that PTEN mRNA 3’UTR was the target of miR-29 family. The PTEN protein expression was decreased after the A549 cells transfected miR a/b/c mimics for 36 h, and PTEN protein expression was increased after H1299 cells transfected miR a/b/c inhibitors for 36 h. The miR-29 family were knocked down in H1299 cells by CRISPR cas9 technology and the proliferation and invasion were significantly decreased compared with NC group. Compared with NC group, the phosphorylation level of Akt, surviving mRNA and protein expression, and the phosphorylation level of FAK were all decreased after miR-29 family was knocked down. Conclusions The miR-29 family promoted the proliferation and invasion of lymph node invasive NSCLC cells by decreasing PTEN expression and abnormally activating p-Akt and p-FAK signaling pathway.

Cite this article

CHEN Chen, YIN Shanshan, GUO Jiahui, GAO Fenghou . Degradation of PTEN mRNA by microRNA-29 family promotes survival and lymph node invasion of non-small cell lung cancer cell[J]. Journal of Internal Medicine Concepts & Practice, 2021 , 16(01) : 37 -44 . DOI: 10.16138/j.1673-6087.2021.01.009

References

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
[2] Osmani L, Askin F, Gabrielson E, et al. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): moving from targeted therapy to immunotherapy[J]. Semin Cancer Biol, 2018, 52 Pt 1: 103-109.
[3] Dai C, Ren Y, Xie D, et al. Does lymph node metastasis have a negative prognostic impact in patients with NSCLC and M1a disease[J]?. J Thorac Oncol, 2016, 11(10): 1745-1754.
[4] Worby CA, Dixon JE. PTEN[J]. Annu Rev Biochem, 2014, 83: 641-669.
[5] Tang JM, He QY, Guo RX, et al. Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis[J]. Lung Cancer, 2006, 51(2): 181-191.
[6] Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay[J]. Nat Rev Genet, 2010, 11(9): 597-610.
[7] Liu H, Cheng L, Cao D, et al. Suppression of miR-21 expression inhibits cell proliferation and migration of liver cancer cells by targeting phosphatase and tensin homolog (PTEN)[J]. Med Sci Monit, 2018, 24: 3571-3577.
[8] Lou Y, Yang X, Wang F, et al. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein[J]. Int J Mol Med, 2010, 26(6): 819-827.
[9] Feng X, Jiang J, Shi S, et al. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway[J]. Int J Oncol, 2016, 49(6): 2600-2610.
[10] Jing ZF, Bi JB, Li ZL, et al. miR-19 promotes the proliferation of clear cell renal cell carcinoma by targeting the FRK-PTEN axis[J]. Onco Targets Ther, 2019, 12: 2713-2727.
[11] Kwon JJ, Factora TD, Dey S, et al. A systematic review of miR-29 in cancer[J]. Mol Ther Oncolytics, 2019, 12: 173-1794.
[12] Robert J. Biology of cancer metastasis[J]. Bull Cancer, 2013, 100(4): 333-342.
[13] Deng H, Wu RL, Zhou HY, et al. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer[J]. World J Gastroenterol, 2006, 12(7): 1013-1017.
[14] Wu Y, Song Y, Xiong Y, et al. MicroRNA-21 (Mir-21) promotes cell growth and invasion by repressing tumor suppressor PTEN in colorectal cancer[J]. Cell Physiol Biochem, 2017, 43(3): 945-958.
[15] Feng C, Yao R, Huang F, et al. High level of PTEN expression is associated with low-grade liver metastasis and satisfactory patient survival in pancreatic cancer[J]. Arch Med Res, 2011, 42(7): 584-588.
[16] Gkountakos A, Sartori G, Falcone I, et al. PTEN in lung cancer: dealing with the problem, building on new knowledge and turning the game around[J]. Cancers (Basel), 2019, 11(8): 1141.
[17] Molinari F, Frattini M. Functions and regulation of the PTEN gene in colorectal cancer[J]. Front Oncol, 2013, 3: 326.
[18] Kim DH, Suh J, Surh YJ, et al. Regulation of the tumor suppressor PTEN by natural anticancer compounds[J]. Ann N Y Acad Sci, 2017, 1401(1): 136-149.
[19] Lu J, Jeong HW, Kong N, et al. Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex[J]. PLoS One, 2009, 4(5): e5577.
[20] Di Giorgio E, Clocchiatti A, Piccinin S, et al. MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation[J]. Mol Cell Biol, 2013, 33(22): 4473-4491.
[21] Poliseno L, Pandolfi PP. PTEN ceRNA networks in human cancer[J]. Methods, 2015, 77-78: 41-50.
[22] Jang SJ, Choi IS, Park G, et al. MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression[J]. Leuk Res, 2016, 47: 172-177.
[23] Yang Y, Guo JX, Shao ZQ. miR-21 targets and inhibits tumor suppressor gene PTEN to promote prostate cancer cell proliferation and invasion: an experimental study[J]. Asian Pac J Trop Med, 2017, 10(1): 87-91.
[24] Alizadeh M, Safarzadeh A, Beyranvand F, et al. The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy[J]. J Cell Physiol, 2019, 234(11): 19280-19297.
[25] Ślusarz A, Pulakat L. The two faces of miR-29[J]. J Cardiovasc Med (Hagerstown), 2015, 16(7): 480-490.
Outlines

/